why choose us

First received: June 26, 2024

Clinical Trial: CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Rotavirus Infections

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Study to Evaluate the Safety and Immunogenicity of CDC-9 Inactivated Rotavirus Adjuvanted Vaccine for Intramuscular Administration in Healthy Adults

Brief Summary: This is a study of CDC-9 inactivated rotavirus vaccine (IRV) for intramuscular administration (IM) in healthy adults aged 18 to 45 years at two dose levels in a 3-dose series.The purpose is to determine if it is safe and if the recipient's immune system responds to the vaccine.

Read more